Loading...
NPI 1629108949 · Harrison, AR · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Chris Taylor Cosmetics, P.A. is a ambulatory surgical clinic/center provider located in Harrison, Arkansas. This profile covers 4 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Chris Taylor Cosmetics, P.A. |
| Address | 1425 Rock Springs Rd |
| City | Harrison |
| State | AR |
| ZIP | 72601 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | March 6, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $6.5M |
| Medicaid | $211.4K |
CHRIS TAYLOR COSMETICS, P.A. is listed as an Ambulatory Surgical Clinic/Center and its billed services are dominated by neuromodulation procedures: insertion and replacement of peripheral, sacral, or gastric neurostimulator pulse generators (code 64590) and implantation of sacral nerve electrodes under imaging guidance (code 64561). The code descriptions indicate a facility performing surgical pocket creation and image-guided electrode implantation rather than typical outpatient cosmetic procedures, so operational capabilities likely include surgical suites, imaging support, and device-handling workflows.
Medicare revenue is highly concentrated: the provider reports $6.5M in total Medicare revenue and its top three Medicare codes account for 99.9% of that revenue. Those top codes are 64590 ($3.7M, 56.7% of Medicare revenue), 64561 ($2.8M, 42.8% of Medicare revenue), and 64595 ($23.7K, 0.4% of Medicare revenue), indicating near-total dependence on a very narrow set of neuromodulation services for Medicare.
Medicaid billing is effectively mono-coded: total Medicaid revenue is $211.4K while code 64561 is reported at $211.5K and accounts for 100.0% of the provider's Medicaid revenue. This shows Medicaid activity is entirely concentrated in the same sacral nerve electrode implantation service that drives much of the Medicare business.
Payer mix is Medicare-dominant: Medicare revenue ($6.5M) far exceeds Medicaid revenue ($211.4K), so the practice is effectively single-payer in scale with Medicare as the primary commercial driver of volume and financial performance. Analysts should treat Medicaid patterns as a very small proportion of overall revenue and focus competitive analysis primarily on Medicare neuromodulation volumes.
The provider is a national outlier on its two highest-volume Medicare codes. Code 64590 ranks #1 of 561 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code) and 64561 ranks #1 of 564 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code), signaling exceptional national concentration and specialization in these procedures. By contrast, the third Medicare code 64595 ranks #2 of 8 providers nationally (71th percentile; typical, unremarkable volume), so only the top two codes confer true national dominance.
On the Medicaid side the provider ranks #1 of 2 providers in-state for 64561 (100th percentile; typical, unremarkable volume), which reflects a top in-state position but within a very small peer set. The in-state competitive signal is therefore limited by the tiny number of reporting peers; being #1 in-state does not necessarily imply large absolute Medicaid volume.
The billing profile suggests an operational model built around device-based neuromodulation: high average paid-per-claim on Medicare for 64590 ($13,044 avg paid/claim, 282 claims) and substantial claim volume for 64561 on Medicare (826 claims, $3,366 avg paid/claim) imply routine implantation procedures and device management workflows. This concentration implies specific resource needs—implantable device inventory, surgical staffing, and imaging capabilities—rather than a broad ambulatory service mix.
The provider has an established presence, with an NPI enumerated on 2007-03-06 (~19 years ago), which supports the interpretation of a sustained, specialized practice rather than a new entrant. Combined with extreme national ranking on its highest-volume Medicare codes, the long tenure reinforces that this is a focused, high-volume neuromodulation operator rather than a generalist outpatient clinic.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 280 | $13,040 | $3.7M |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 830 | $3,370 | $2.8M |
| 64595 | The provider revises or removes a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that has… | 20 | $1,580 | $23.7K |
| 64585 | The provider revises or removes a neurostimulator electrode array on a peripheral nerve, the portion of the nervous system lying outside the brain and spinal cord. This service is generally done for… | 20 | $610 | $9.2K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 4 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 220 | $980 | $211.5K |
How this provider's Medicaid billing volume and revenue compare to other Arkansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arkansas median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 1 | 10 | 130 | $860 | $108.5K |
Other providers in the same ZIP code as Chris Taylor Cosmetics, P.A., ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.